EyePoint Pharmaceuticals, Inc. — Director's Dealing 2017

Jun 29, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: pSivida Corp. (PSDV)
CIK: 0001314102
Period of Report: 2017-06-27

Reporting Person: JORN DEBORA (EVP, Corp. & Comm'l Dev.)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-06-27	Restricted Stock Units	$	A	45000	Acquired		Common Stock (45000)	Direct
2017-06-27	Stock Option (right to buy)	$1.77	A	90000	Acquired	2027-06-27	Common Stock (90000)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.

F2: The restricted stock units will vest in three equal annual installments beginning June 27, 2018. Vested shares will be delivered to the reporting person within 30 days following each respective vesting date.

F3: The option to purchase will vest and become exercisable in three equal annual installments beginning June 27, 2018.